Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Once you reach a dose of semaglutide that produces consistent weight loss without intolerable side effects, you've entered the maintenance phase. This stabilization period is critical—clinical trials show that people who stay on their maintenance dose for 12 months or longer maintain 80% of their maximum weight loss. PlexusDx helps you navigate this phase with transparent, flat-rate pricing that doesn't change as your dose adjusts.
What Does Maintenance Dose Mean in GLP-1 Therapy?
In weight loss medicine, a maintenance dose is the amount of medication that achieves your target weight loss response while keeping side effects manageable. Unlike a dose-escalation phase where you increase gradually, maintenance is your steady state—the dose you may stay on indefinitely. For semaglutide, maintenance typically ranges from 1.0 to 2.4 mg weekly, depending on your individual response and tolerability.
The maintenance phase doesn't mean your dose is permanent. Some people need a slight upward adjustment months into treatment if their weight loss plateaus. Others find that their current dose continues working well for years. The key is that once you've found your therapeutic sweet spot, the goal shifts from climbing toward higher doses to sustaining the benefits you've already achieved.
Clinical data from the STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that patients maintaining a stable dose experienced durable weight reduction. People who discontinued after reaching maintenance regained weight more quickly than those who continued. This underscores why long-term maintenance dosing is the realistic strategy for lasting success.
How Maintenance Dose Differs from Titration Phase
The titration phase is your ramp-up period. You start with a low dose—usually 0.25 mg of semaglutide weekly—and increase by 0.25 mg every four weeks until you reach your maintenance target or hit a dose that controls your appetite effectively. During this 4–6 month climb, side effects like nausea are common but typically fade as your body adapts. Once you stop increasing, you've entered maintenance.
Maintenance is fundamentally different because the focus shifts from finding your therapeutic dose to sustaining it. Your dose stays the same week to week, your body has fully adjusted to the medication, and most initial side effects have resolved. You're no longer climbing a dose ladder; you're holding steady while your body continues to manage weight over the long term.
One critical difference: during titration, your price does not change with each dose increase at PlexusDx. The company's flat-rate model means you pay one price whether you're at 0.5 mg or 2.4 mg. This pricing transparency removes financial surprises and aligns incentive—your dose may go up, but your monthly cost stays stable.
Signs You've Reached Your Optimal Maintenance Dose
Your optimal maintenance dose is the lowest dose that gives you meaningful appetite suppression and consistent weight loss without causing unacceptable nausea, vomiting, or other side effects. Three key signals suggest you've found it: stable week-to-week weight loss averaging 1–2 pounds per week, controlled hunger and food cravings, and side effects that are minimal or absent. If you're losing weight, your appetite is suppressed, and you feel physically well, your body is telling you the dose is right.
Some people reach this point at 1.0 mg weekly; others need 2.0 or 2.4 mg. Genetics play a role in how your body responds to GLP-1 medication. PlexusDx offers the Precision Peptide Genetic Test, which examines key genetic variants like GLP1R rs6923761 and GIPR rs1800437 to help predict your peptide pathway sensitivity. Understanding your genetic profile can inform your prescriber whether a lower or higher maintenance dose may be more effective for your body.
You should not increase your dose if you're already losing weight steadily and tolerating the medication well. Pushing to a higher dose when the current one is working invites unnecessary side effects without additional benefit. The goal of maintenance is sustainability, not maximization.
Long-Term Maintenance: Sustainability and Real-World Success
Reaching maintenance dose is a milestone, but it's not the finish line. Real-world success means staying on your maintenance dose for months and years—a commitment that requires accessible pricing, reliable supply, and clinical support. Studies tracking patients beyond the initial trial period show that weight regain occurs within months of stopping semaglutide, even after significant initial loss. Maintenance dosing works only if you continue taking it.
PlexusDx compounded semaglutide starts at $149 per month regardless of your maintenance dose. This flat-rate model removes the financial barriers that often cause patients to skip doses or discontinue early. Combined with no insurance requirement, no membership fees, and HSA/FSA eligibility, PlexusDx removes cost as an obstacle to sustained treatment.
Your prescriber may adjust your maintenance dose if you hit a weight-loss plateau several months in. A modest increase—from 1.5 mg to 2.0 mg, for example—can restart momentum without starting over. The key is that your price remains the same, supporting you through dose adjustments without unexpected cost spikes. This stability is critical for patients building long-term treatment plans.
Personalizing Your Maintenance Dose with Genetic Insights
Not everyone's maintenance dose is the same, and genetics explain part of why. The Precision Peptide Genetic Test offered by PlexusDx analyzes 49 peptides across 14 metabolic and appetite pathways, including genetic variants in GLP1R, GIPR, FTO, and MC4R genes. These variants influence how your body produces, releases, and responds to appetite-regulating hormones. Knowing your genetic profile helps your prescriber predict whether you'll respond best at 1.0 mg, 1.5 mg, 2.0 mg, or higher.
For example, certain variants in the GLP1R gene may predict stronger receptor sensitivity, suggesting you could reach meaningful weight loss at a lower maintenance dose. Other variants in the GIPR pathway may indicate you'll benefit from a slightly higher dose. The test costs $99 as an add-on after your first month of treatment, giving you data-driven guidance to optimize your maintenance strategy without unnecessary trial and error.
Genetic testing is not about perfection—it's about informed decision-making. By understanding your peptide pathway predispositions, you and your prescriber can personalize your maintenance dose more efficiently, anticipate side effects, and plan a sustainable long-term approach.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long will I need to stay on my maintenance dose of semaglutide?
Long-term maintenance is typically indefinite. Clinical data shows that weight regain begins within weeks to months of stopping semaglutide, even after achieving significant weight loss. Most people who succeed with GLP-1 therapy remain on their maintenance dose for years. Your prescriber can help determine whether ongoing treatment aligns with your health goals.
Can my maintenance dose go down, or does it only increase?
Maintenance doses typically stay stable, but individual responses vary. Some patients find their current dose continues working indefinitely; others may need a small increase if weight loss plateaus. Dose reduction is less common but possible if you experience persistent side effects. Work with your prescriber to monitor your response and adjust only when clinically indicated.
Will I pay more for a higher maintenance dose with PlexusDx?
No. PlexusDx compounded semaglutide is priced flat at $149 per month, regardless of whether your maintenance dose is 1.0 mg or 2.4 mg weekly. The pricing model ensures your cost remains stable even if your dose increases, removing financial barriers to optimal treatment.
How is compounded semaglutide different from brand-name Wegovy?
Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Wegovy but costs significantly less and requires no insurance. PlexusDx sources from licensed 503A facilities and offers the same mechanism of action at a more accessible price point. Compounded medications are not FDA-approved, but they are legally manufactured under strict pharmaceutical standards.
Can the Precision Peptide Genetic Test help predict my ideal maintenance dose?
Yes. The test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R genes, which influence your sensitivity to GLP-1 medication and baseline metabolic rate. Understanding your peptide pathway predispositions helps your prescriber anticipate whether you'll respond optimally at a lower or higher maintenance dose, reducing trial-and-error and supporting faster, more confident dosing decisions.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Wegovy Results: Expected Weight Loss Timeline and Success Rates
Does Zepbound Have More Side Effects Than Wegovy? A Comprehensive Comparison